Prostate short-chain dehydrogenase reductase I (PSDR1): A new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1611-1618

  Lin, Biaoyang ^a   White, James T ^a   Ferguson, Camari ^c   Wang, Shunyou ^a   Vessella, Robert ^a   Bumgarner, Roger ^a   True, Lawrence D ^a   Hood, Leroy ^b   Nelson, Peter S ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SHORT CHAIN DEHYDROGENASE REDUCTASE 1; STEROID REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; CELL DEATH; CHROMOSOME 14Q; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANDROGENS; BASE SEQUENCE; CHROMOSOME MAPPING; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA, NEOPLASM; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0035866347     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cancer statistics 1999
2. Studies on prostate cancer 1: The effect of castration of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
3. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
4. On the prevention and therapy of prostate cancer by androgen administration
5. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers
6. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
7. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells
8. Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest
9. Androgen receptor mutations in prostate cancer
10. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model
11. Intermittent androgen deprivation for clinically localized prostate cancer: Initial experience
12. Intermittent androgen suppression in the management of prostate cancer
13. Prostate-localized and androgen-regulated expression of the membranebound serine protease TMPRSS2
14. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
15. Androgens and the control of lipid metabolism in human prostate cancer cells
16. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP
17. Steroid hormones: Chemistry, biosynthesis, and metabolism
18. Regulation of HSD17B1 and SRD5A1 in lymphocytes
19. Androgen and glucocorticoid regulation of androgen receptor cDNA expression
20. PEDB: The prostate expression database
21. An expressed-sequence-tag database of the human prostate: Sequence analysis of 1168 cDNA clones
22. Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5′ promoter region of the gene
23. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
24. Prostate-specific and androgen-dependent expression of a novel homeobox gene
25. Molecular cloning and characterization of prostate, an androgen-regulated serine protease with prostate-restricted expression
26. PART-1: A novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12
27. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
28. Basic local alignment search tool
29. The Blocks database - A system for protein classification
30. Short-chain dehydrogenases/reductases (SDR)
31. Structure of human estrogenic 17-β-hydroxysteroid dehydrogenase at 2.20 A resolution
32. Organization and expression of eucaryotic split genes coding for proteins
33. Alternative splicing of the latency-related transcript of bovine herpesvirus I yields RNAs containing unique open reading frames
34. Large scale sequencing specific neural networks for promoter and splice site recognition
35. A consensus DNA-binding site for the androgen receptor
36. The constitution of a progesterone response element
37. Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat α2 macroglobulin gene
38. Characteristics of short-chain alcohol dehydrogenases and related enzymes
39. Characteristics of a highly labile human type 5 17-β-hydroxysteroid dehydrogenase
40. Male pseudohermaphroditism caused by mutations of testicular 17-β-hydroxysteroid dehydrogenase 3
41. Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate
42. Characterization of 17-β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate
43. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
44. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
45. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
46. Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk
47. Mechanism of induction of mouse kidney alcohol dehydrogenase by androgen. Androgen-induced stimulation of transcription of the Adh-1 gene
48. Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells
49. Complete amino acid sequence of human placental 17-β-hydroxysteroid dehydrogenase deduced from cDNA
50. Expression and regulation of 17-β-hydroxysteroid dehydrogenase type I
51. Expression cloning and characterization of human 17-β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 α-hydroxysteroid dehydrogenase activity
52. Molecular cloning of a novel widely expressed human 80 kDa 17-β-hydroxysteroid dehydrogenase IV
53. Expression and characterization of recombinant type 2 3 α-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3α/17-β-HSD activity and cellular distribution
54. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice